Profile banner
Neil R. Parikh, MD MBA

Neil R. Parikh, MD MBA

Physician, investor, and expert in prostate cancer radiotherapy

neilparikh
Temple, Texas
Joined June 2025
Favicon imageneilrparikhmd.com
Favicon imagelinkedin.com

Network

5K connections
💼
McKinsey Consulting Leaders
💡
Ex-McKinsey Strategy & Product Leaders
💰
Healthcare & Life Sciences Investors
🐻
UCLA Health Professionals
☢️
Radiation Oncology Professionals
🚀
Startup Founders
🩺
MDs

Summary

Neil Parikh is a physician and investor with a unique blend of clinical expertise in radiation oncology, particularly in prostate cancer treatment using advanced techniques like SBRT, and a strong background in healthcare venture capital. healthwildcatters+1
He has a comprehensive educational background, combining medicine (MD from Baylor College of Medicine) with business acumen (MBA from Harvard Business School) and economics (BA from Rice University), which informs his dual career path in clinical practice and healthcare investment. healthwildcatters+1
His career includes significant experience in healthcare consulting at McKinsey & Company, where he advised various stakeholders in the healthcare industry, demonstrating an interest in health policy and economics. healthwildcatters+2
During his residency at UCLA, he was actively involved in research focusing on value-based healthcare in radiation oncology and the integration of novel technologies. He also co-founded CranioView, a medical device company, as part of the UCLA Biodesign Fellowship. healthwildcatters+3
Neil actively publishes research, particularly on the cost-effectiveness and implementation of new technologies and methodologies in radiation oncology, such as telemedicine and different guidance systems for SBRT. nih+2

Work

Education

Projects

Writing

Time-Driven Activity-Based Costing Analysis of Telemedicine Services in Radiation Oncology

October 1, 2020

Evaluated the change in resource use associated with transitioning to telemedicine in a radiation oncology department, finding significant cost savings for departments, healthcare workers, and patients.

Favicon imagepubmed.ncbi.nlm.nih.gov

Time-Driven Activity-Based Costing Comparison of CT-Guided Versus MR-Guided SBRT

Compared the costs of delivering care with CT-guided versus MR-guided radiation therapy for hepatocellular carcinoma, finding MRgRT to be 18% more expensive under baseline assumptions.

Favicon imageascopubs.org